Tang Capital Management LLC Ventyx Biosciences, Inc. Call Options Transaction History
Tang Capital Management LLC
- $1.67 Billion
- Q2 2025
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding VTYX
# of Institutions
119Shares Held
49.1MCall Options Held
70.4KPut Options Held
51.4K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.9MShares$15.5 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.77MShares$12.5 Million0.0% of portfolio
-
Affinity Asset Advisors, LLC New York, NY4.54MShares$11.9 Million1.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.16MShares$8.32 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.4MShares$6.3 Million0.01% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $149M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...